| scholarly article | Q13442814 |
| P356 | DOI | 10.1111/J.1476-5381.2012.02208.X |
| P8608 | Fatcat ID | release_sz6jxc7jarhbrcmmxdkjgh6f4e |
| P932 | PMC publication ID | 3687660 |
| P698 | PubMed publication ID | 22970888 |
| P50 | author | Giulio G. Muccioli | Q38601106 |
| P2093 | author name string | Didier M Lambert | |
| Barbara Bosier | |||
| P2860 | cites work | Cannabinoid-induced mesenteric vasodilation through an endothelial site distinct from CB1 or CB2 receptors | Q24642509 |
| A comprehensive profile of brain enzymes that hydrolyze the endocannabinoid 2-arachidonoylglycerol | Q24649418 | ||
| The orphan receptor GPR55 is a novel cannabinoid receptor | Q24670137 | ||
| Identification of GPR55 as a lysophosphatidylinositol receptor | Q28244299 | ||
| Novel mechanistic class of fatty acid amide hydrolase inhibitors with remarkable selectivity | Q28253977 | ||
| Characterization of palmitoylethanolamide transport in mouse Neuro-2a neuroblastoma and rat RBL-2H3 basophilic leukaemia cells: comparison with anandamide | Q28363051 | ||
| Presynaptic mechanisms underlying cannabinoid inhibition of excitatory synaptic transmission in rat striatal neurons | Q28363375 | ||
| Cannabinoid CB(1) receptors in the basal ganglia and motor response to activation or blockade of these receptors in parkin-null mice | Q28585963 | ||
| Isolation and structure of a brain constituent that binds to the cannabinoid receptor | Q29547476 | ||
| Modulation of anxiety through blockade of anandamide hydrolysis | Q29615902 | ||
| Discovering potent and selective reversible inhibitors of enzymes in complex proteomes | Q31141832 | ||
| CB1 cannabinoid receptor inhibits synaptic release of glutamate in rat dorsolateral striatum | Q31817073 | ||
| The nuclear receptor peroxisome proliferator-activated receptor-alpha mediates the anti-inflammatory actions of palmitoylethanolamide. | Q33844609 | ||
| Antinociceptive activity of the endogenous fatty acid amide, palmitylethanolamide. | Q33953174 | ||
| Selective ligands and cellular effectors of a G protein-coupled endothelial cannabinoid receptor | Q33964574 | ||
| Anandamide administration alone and after inhibition of fatty acid amide hydrolase (FAAH) increases dopamine levels in the nucleus accumbens shell in rats | Q48485540 | ||
| Influence of cannabinoids on electrically evoked dopamine release and cyclic AMP generation in the rat striatum. | Q48631827 | ||
| Low dose anandamide affects food intake, cognitive function, neurotransmitter and corticosterone levels in diet-restricted mice. | Q52169249 | ||
| Activation of TRPA1 channels by the fatty acid amide hydrolase inhibitor 3'-carbamoylbiphenyl-3-yl cyclohexylcarbamate (URB597). | Q53577604 | ||
| Time-course of the effects of anandamide, the putative endogenous cannabinoid receptor ligand, on extrapyramidal function. | Q54001516 | ||
| Increasing endogenous 2-arachidonoylglycerol levels counteracts colitis and related systemic inflammation | Q60843038 | ||
| delta 9-Tetrahydrocannabinol affects mesolimbic dopaminergic activity in the female rat brain: interactions with estrogens | Q72231433 | ||
| The endogenous cannabinoid receptor ligand, anandamide, inhibits the motor behavior: role of nigrostriatal dopaminergic neurons | Q72302141 | ||
| Animal research: reporting in vivo experiments: the ARRIVE guidelines | Q34116755 | ||
| Design, synthesis, and structure-activity relationships of alkylcarbamic acid aryl esters, a new class of fatty acid amide hydrolase inhibitors. | Q34200866 | ||
| Guide to Receptors and Channels (GRAC), 5th edition | Q34228968 | ||
| Antidepressant-like activity and modulation of brain monoaminergic transmission by blockade of anandamide hydrolysis | Q34234907 | ||
| Involvement of N-acylethanolamine-hydrolyzing acid amidase in the degradation of anandamide and other N-acylethanolamines in macrophages | Q34449902 | ||
| Involvement of the endocannabinoid system in drug addiction | Q34495242 | ||
| An anatomical and temporal portrait of physiological substrates for fatty acid amide hydrolase | Q34503405 | ||
| Effects of fatty acid amide hydrolase inhibition on neuronal responses to nicotine, cocaine and morphine in the nucleus accumbens shell and ventral tegmental area: involvement of PPAR-alpha nuclear receptors. | Q35196626 | ||
| Endogenous fatty acid ethanolamides suppress nicotine-induced activation of mesolimbic dopamine neurons through nuclear receptors | Q35202878 | ||
| Actions of the FAAH inhibitor URB597 in neuropathic and inflammatory chronic pain models | Q35545219 | ||
| Repeated cannabinoid administration increases indices of noradrenergic activity in rats | Q35928133 | ||
| Kinase signaling cascades that modulate peroxisome proliferator-activated receptors | Q36076085 | ||
| Pharmacological profile of the selective FAAH inhibitor KDS-4103 (URB597). | Q36533477 | ||
| An optimized GC-MS method detects nanomolar amounts of anandamide in mouse brain | Q36591816 | ||
| Inhibition of anandamide hydrolysis by cyclohexyl carbamic acid 3'-carbamoyl-3-yl ester (URB597) reverses abuse-related behavioral and neurochemical effects of nicotine in rats | Q37146387 | ||
| Fatty acid amide hydrolase (FAAH) inhibition enhances memory acquisition through activation of PPAR-alpha nuclear receptors. | Q37194497 | ||
| Endocannabinoid biosynthesis and inactivation, from simple to complex | Q37715385 | ||
| Guidelines for reporting experiments involving animals: the ARRIVE guidelines | Q39512979 | ||
| Concomitant activation of adenylyl cyclase suppresses the opposite influences of CB(1) cannabinoid receptor agonists on tyrosine hydroxylase expression | Q39919951 | ||
| Agonist selective modulation of tyrosine hydroxylase expression by cannabinoid ligands in a murine neuroblastoma cell line | Q40125857 | ||
| Identification of a novel endocannabinoid-hydrolyzing enzyme expressed by microglial cells | Q40158906 | ||
| Fatty acid amide hydrolase inhibitors display broad selectivity and inhibit multiple carboxylesterases as off-targets | Q40184192 | ||
| Differential responses of PPARalpha, PPARdelta, and PPARgamma reporter cell lines to selective PPAR synthetic ligands | Q40394364 | ||
| T0070907, a selective ligand for peroxisome proliferator-activated receptor gamma, functions as an antagonist of biochemical and cellular activities | Q40747044 | ||
| Potentiation of electrical and chemical synaptic transmission mediated by endocannabinoids. | Q41772804 | ||
| Inhibition of fatty acid amide hydrolase produces PPAR-alpha-mediated analgesia in a rat model of inflammatory pain | Q42248322 | ||
| Endocannabinoid-mediated rescue of striatal LTD and motor deficits in Parkinson's disease models | Q42508054 | ||
| Involvement of vanilloid-like receptors in the effects of anandamide on motor behavior and nigrostriatal dopaminergic activity: in vivo and in vitro evidence. | Q42624110 | ||
| Astrocytes in culture produce anandamide and other acylethanolamides. | Q43935534 | ||
| Presynaptic Facilitation of Glutamatergic Synapses to Dopaminergic Neurons of the Rat Substantia Nigra by Endogenous Stimulation of Vanilloid Receptors | Q44418969 | ||
| Reversible inhibitors of fatty acid amide hydrolase that promote analgesia: evidence for an unprecedented combination of potency and selectivity | Q44903331 | ||
| Characterization of the fatty acid amide hydrolase inhibitor cyclohexyl carbamic acid 3'-carbamoyl-biphenyl-3-yl ester (URB597): effects on anandamide and oleoylethanolamide deactivation. | Q45173372 | ||
| CAY10499, a novel monoglyceride lipase inhibitor evidenced by an expeditious MGL assay | Q46315889 | ||
| Inhibition of fatty acid amide hydrolase and cyclooxygenase-2 increases levels of endocannabinoid related molecules and produces analgesia via peroxisome proliferator-activated receptor-alpha in a model of inflammatory pain | Q46555927 | ||
| Elevation of endocannabinoid levels in the ventrolateral periaqueductal grey through inhibition of fatty acid amide hydrolase affects descending nociceptive pathways via both cannabinoid receptor type 1 and transient receptor potential vanilloid typ | Q46801175 | ||
| Role in anxiety behavior of the endocannabinoid system in the prefrontal cortex | Q46962183 | ||
| Predominant expression of lysosomal N-acylethanolamine-hydrolyzing acid amidase in macrophages revealed by immunochemical studies | Q48186886 | ||
| Effects of the fatty acid amide hydrolase inhibitor URB597 on the sleep-wake cycle, c-Fos expression and dopamine levels of the rat. | Q48254078 | ||
| Cannabidiol, a constituent of Cannabis sativa, modulates sleep in rats | Q48470514 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 794-807 | |
| P577 | publication date | 2013-06-01 | |
| P1433 | published in | British Journal of Pharmacology | Q919631 |
| P1476 | title | The FAAH inhibitor URB597 efficiently reduces tyrosine hydroxylase expression through CB₁- and FAAH-independent mechanisms | |
| P478 | volume | 169 |
| Q38808034 | An update on PPAR activation by cannabinoids. |
| Q64956878 | Anti-Inflammatory Effects by Pharmacological Inhibition or Knockdown of Fatty Acid Amide Hydrolase in BV2 Microglial Cells. |
| Q36254356 | Blocking of fatty acid amide hydrolase activity with PF-04457845 in human brain: a positron emission tomography study with the novel radioligand [(11)C]CURB. |
| Q53416709 | Cannabidiol regulates behavioural alterations and gene expression changes induced by spontaneous cannabinoid withdrawal. |
| Q30574567 | Effects of the fatty acid amide hydrolase inhibitor URB597 on pain-stimulated and pain-depressed behavior in rats |
| Q35531797 | Simultaneous inhibition of fatty acid amide hydrolase and monoacylglycerol lipase shares discriminative stimulus effects with Δ9-tetrahydrocannabinol in mice |
Search more.